Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Therapeutics and Clinical Risk Management|September 22, 2010
Correlation of random urine protein creatinine (P-C) ratio with 24-hour urine protein and P-C ratio, based on physical activity: a pilot studySeyed-Ali Sadjadi, Navin JaipaulHematology Reports|August 9, 2016
Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with BortezomibNavin Jaipaul, Alexander Pi, Zhiwei ZhangInternational Journal of Women'S Dermatology|August 25, 2020
The rise and evolution of COVID-19Mohsen Baghchechi, Navin Jaipaul, Sharon E JacobJournal of Critical Care|June 9, 2015
Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albuminZhiwei Zhang, Geetha Maddukuri, Navin Jaipaul, et al.Digestive Diseases and Sciences|December 24, 2014
A Treat-to-Target Concept to Guide the Medical Management of Hepatorenal SyndromeCindy X Cai, Geetha Maddukuri, Navin Jaipaul, et al.International Journal of Nephrology and Renovascular Disease|June 19, 2013
Ion-selective electrode and anion gap range: What should the anion gap be?Seyed-Ali Sadjadi, Rendell Manalo, Navin Jaipaul, et al.Therapeutics and Clinical Risk Management|June 8, 2010
Obesity is not associated with contrast nephropathyNavin Jaipaul, Rendell Manalo, Seyed-Ali Sadjadi, et al.International Journal of Women'S Dermatology|May 5, 2020
Art of prevention: Life in the time of coronavirusMohsen Baghchechi, Jeffery Dunn, Navin Jaipaul, et al.JRSM Open|May 18, 2016
Rare and unusual clinicopathologic presentation of renal AL amyloidosisAndrew Logan, Craig Zuppan, Alexander Pi, et al.Therapeutics and Clinical Risk Management|August 27, 2009
A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockersSeyed Ali Sadjadi, James I McMillan, Navin Jaipaul, et al.Pageof 2